Inactive Instrument

Analyst Reco. National Instruments Corporation

Equities

NATI

US6365181022

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

UBS Raises National Instruments' Price Target to $60 From $53, Maintains Neutral Rating	23-04-19	MT
Jefferies Downgrades National Instruments to Hold From Buy, Adjusts Price Target to $60 From $55	23-04-14	MT
ANALYST RECOMMENDATIONS : Mosaic, Inspire Medical, London Stock Exchange, ResMed, Whitbread...	23-04-14
Susquehanna Downgrades National Instruments to Neutral From Positive, Cuts Price Target to $60 From $70	23-04-13	MT
Morningstar Upgrades National Instruments to Hold From Sell, Raises Price Target to $60 From $48	23-04-12	MT
Morgan Stanley Downgrades National Instruments to Eqaulweight From Overweight, Raises Price Target to $60 From $52	23-04-12	MT
UBS Adjusts National Instruments Price Target to $53 From $43, Maintains Neutral Rating	23-02-02	MT
Baird Downgrades National Instruments to Neutral From Outperform, Adjusts Price Target to $55 From $50	23-02-01	MT
Morgan Stanley Reiterates National Instruments to Overweight With $52 Price Target	23-01-17	MT
Morgan Stanley Lifts Price Target on National Instruments to $52 From $47, Maintains Overweight Rating	22-12-13	MT
Jefferies Starts National Instruments at Buy With $50 Price Target	22-11-22	MT
ANALYST RECOMMENDATIONS : Activision, BP, HubSpot, Procter & Gamble, Vodafone...	22-11-22
Morgan Stanley Adjusts Price Target on National Instruments to $47 From $49, Maintains Overweight Rating	22-10-28	MT
Goldman Sachs Adjusts Price Target on National Instruments to $44 From $49, Reiterates Buy Rating	22-10-28	MT
UBS Initiates National Instruments at Neutral Rating with $43 PT, Notes 'Compelling' Double-Digit Growth Opportunity But Sees Stock as Show-Me Story	22-10-20	MT
Morgan Stanley Adjusts National Instruments' Price target to $49 from $46, Keeps Overweight Rating	22-10-11	MT
JPMorgan Chase Adjusts Price Target on National Instruments to $46 From $43, Keeps Neutral Rating	22-10-10	MT
JPMorgan Raises National Instruments Price Target to $43 From $40, Maintains Neutral Rating	22-09-16	MT
Morgan Stanley Adjusts Price Target on National Instruments to $46 From $44, Maintains Overweight Rating	22-09-16	MT
Goldman Sachs Raises Price Target on National Instruments to $49 From $43, Notes 'Strong' 2023 Outlook, Keeps Buy Rating	22-08-01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. National Instruments Corporation

Equities

NATI

US6365181022

Analyst Reco.

Filters